Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2019

Open Access 01-12-2019 | Oral Cancer | Case report

Metastasis of lower gingival squamous cell carcinoma to buccinator lymph node: case report and review of the literature

Authors: Kaho Takada, Takeshi Kuroshima, Hiroaki Shimamoto, Toshimitsu Ohsako, Kou Kayamori, Tohru Ikeda, Hiroyuki Harada

Published in: World Journal of Surgical Oncology | Issue 1/2019

Login to get access

Abstract

Background

Metastasis of oral cancer to the buccinator lymph nodes (BN) is uncommon. The antegrade lymphatic flow in patients with normal anatomy and physiology makes metastasis of lower gingival cancer to BN unlikely.

Case presentation

A 67-year-old woman presented with a 46 × 25-mm tumor on her lower gingiva, along with metastatic foci in BN and cervical lymph nodes. After neoadjuvant chemotherapy, she underwent radical resection of the primary tumor and BN, along with neck dissection. Following surgery, she received adjuvant chemoradiotherapy. Two years after treatment, there has been no evidence of tumor recurrence or metastasis.

Conclusion

This is the first report of lower gingival squamous cell carcinoma with metastasis to BN. Metastasis to BN from lower gingival cancer is very rare but should be considered in patients with locally advanced tumors or tumors that metastasize to the submandibular node.
Literature
1.
go back to reference Petsinis V, Papadogeorgakis N, Evangelou I, Goutzanis L, Pandelidaki E, Alexandridis C. Metastases to supramandibular facial lymph nodes in patients with squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg. 2009;67:1401–8.CrossRef Petsinis V, Papadogeorgakis N, Evangelou I, Goutzanis L, Pandelidaki E, Alexandridis C. Metastases to supramandibular facial lymph nodes in patients with squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg. 2009;67:1401–8.CrossRef
2.
go back to reference Xie L, Zhou X, Huang W, Chen J, Yu J, Li Z. Facial lymph node involvement as a prognostic factor for patient survival in oral cavity squamous cell carcinoma. Tumour Biol. 2016;37:3489–96.CrossRef Xie L, Zhou X, Huang W, Chen J, Yu J, Li Z. Facial lymph node involvement as a prognostic factor for patient survival in oral cavity squamous cell carcinoma. Tumour Biol. 2016;37:3489–96.CrossRef
3.
go back to reference Tart RP, Mukherji SK, Avino AJ, Stringer SP, Mancuso AA. Facial lymph nodes: normal and abnormal CT appearance. Radiology. 1993;188:695–700.CrossRef Tart RP, Mukherji SK, Avino AJ, Stringer SP, Mancuso AA. Facial lymph nodes: normal and abnormal CT appearance. Radiology. 1993;188:695–700.CrossRef
4.
go back to reference Haagensen C. The lymphatics in cancer. 1st ed. Philadelphia: W.B. Saunders; 1972. Haagensen C. The lymphatics in cancer. 1st ed. Philadelphia: W.B. Saunders; 1972.
5.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.CrossRef Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.CrossRef
6.
go back to reference Harada H, Omura K, Tomioka H, Nakayama H, Hiraki A, Shinohara M, Yoshihama Y, Shintani S. Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma. Cancer Chemother Pharmacol. 2013;71:1059–64.CrossRef Harada H, Omura K, Tomioka H, Nakayama H, Hiraki A, Shinohara M, Yoshihama Y, Shintani S. Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma. Cancer Chemother Pharmacol. 2013;71:1059–64.CrossRef
7.
go back to reference Pan WR, Le Roux CM, Briggs CA. Variations in the lymphatic drainage pattern of the head and neck: further anatomic studies and clinical implications. Plast Reconstr Surg. 2011;127:611–20.CrossRef Pan WR, Le Roux CM, Briggs CA. Variations in the lymphatic drainage pattern of the head and neck: further anatomic studies and clinical implications. Plast Reconstr Surg. 2011;127:611–20.CrossRef
8.
go back to reference Kimura Y, Hanazawa T, Okano T. Analysis of cases with the buccinator and mandibular node metastases. Dent Radiol. 2000;39:208–17. Kimura Y, Hanazawa T, Okano T. Analysis of cases with the buccinator and mandibular node metastases. Dent Radiol. 2000;39:208–17.
9.
go back to reference Maruoka Y, Ando T, Ogiuchi Y, Motojima A, Okajima A, Ogiuchi H. Two cases of buccal mucosal squamous cell carcinoma with buccinator lymph node metastases. Jpn J Oral Diagn/Oral Med. 2005;18:285–9. Maruoka Y, Ando T, Ogiuchi Y, Motojima A, Okajima A, Ogiuchi H. Two cases of buccal mucosal squamous cell carcinoma with buccinator lymph node metastases. Jpn J Oral Diagn/Oral Med. 2005;18:285–9.
10.
go back to reference Miyazaki A, Ide T, Koguchi M, Suyama T, Nagai I, Konama G. A case of plasmacytoma in the maxillary alveolar process with buccal lymph node involvment. Jpn J Oral Maxillofac Surg. 1999;45:623–5.CrossRef Miyazaki A, Ide T, Koguchi M, Suyama T, Nagai I, Konama G. A case of plasmacytoma in the maxillary alveolar process with buccal lymph node involvment. Jpn J Oral Maxillofac Surg. 1999;45:623–5.CrossRef
11.
go back to reference Robbins JP, Fitz-Hugh GS, Constable WC. Involvement of the buccinator node in facial malignancy. Arch Otolaryngol. 1971;94:356–8.CrossRef Robbins JP, Fitz-Hugh GS, Constable WC. Involvement of the buccinator node in facial malignancy. Arch Otolaryngol. 1971;94:356–8.CrossRef
12.
go back to reference Jinkins JR. Computed tomography of the cranio-cervical lymphatic system: anatomical and functional considerations. Neuroradiology. 1987;29:317–26.CrossRef Jinkins JR. Computed tomography of the cranio-cervical lymphatic system: anatomical and functional considerations. Neuroradiology. 1987;29:317–26.CrossRef
13.
go back to reference Sheahan P, Colreavy M, Toner M, Timon CV. Facial node involvement in head and neck cancer. Head Neck. 2004;26:531–6.CrossRef Sheahan P, Colreavy M, Toner M, Timon CV. Facial node involvement in head and neck cancer. Head Neck. 2004;26:531–6.CrossRef
14.
go back to reference Matsuzuka T, Kano M, Ogawa H, Miura T, Tada Y, Matsui T, Yokoyma S, Suzuki Y, Suzuki M, Omori K. Sentinel node mapping for node positive oral cancer: potential to predict multiple metastasis. Laryngoscope. 2008;118:646–9.CrossRef Matsuzuka T, Kano M, Ogawa H, Miura T, Tada Y, Matsui T, Yokoyma S, Suzuki Y, Suzuki M, Omori K. Sentinel node mapping for node positive oral cancer: potential to predict multiple metastasis. Laryngoscope. 2008;118:646–9.CrossRef
15.
go back to reference Lorch JH, Goloubeva O, Haddad RI, Cullen K, Sarlis N, Tishler R, Tan M, Fasciano J, Sammartino DE, Posner MR, Group TS. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol. 2011;12:153–9.CrossRef Lorch JH, Goloubeva O, Haddad RI, Cullen K, Sarlis N, Tishler R, Tan M, Fasciano J, Sammartino DE, Posner MR, Group TS. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol. 2011;12:153–9.CrossRef
16.
go back to reference Zhong LP, Zhang CP, Ren GX, Guo W, William WN, Hong CS, Sun J, Zhu HG, Tu WY, Li J, et al. Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma. Oncotarget. 2015;6:18707–14.PubMedPubMedCentral Zhong LP, Zhang CP, Ren GX, Guo W, William WN, Hong CS, Sun J, Zhu HG, Tu WY, Li J, et al. Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma. Oncotarget. 2015;6:18707–14.PubMedPubMedCentral
17.
go back to reference Patil VM, Noronha V, Joshi A, Banavali SD, Muddu V, Prabhash K. Preoperative chemotherapy and metronomic scheduling of chemotherapy in locally advanced oral cancers. Oncology. 2016;91(Suppl 1):35–40.CrossRef Patil VM, Noronha V, Joshi A, Banavali SD, Muddu V, Prabhash K. Preoperative chemotherapy and metronomic scheduling of chemotherapy in locally advanced oral cancers. Oncology. 2016;91(Suppl 1):35–40.CrossRef
18.
go back to reference Shirasaka T, Shimamato Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, Fukushima M. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anti-Cancer Drugs. 1996;7:548–57.CrossRef Shirasaka T, Shimamato Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, Fukushima M. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anti-Cancer Drugs. 1996;7:548–57.CrossRef
19.
go back to reference Shirasaka T. Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas. Jpn J Clin Oncol. 2009;39:2–15.CrossRef Shirasaka T. Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas. Jpn J Clin Oncol. 2009;39:2–15.CrossRef
20.
go back to reference Koizumi W, Boku N, Yamaguchi K, Miyata Y, Sawaki A, Kato T, Toh Y, Hyodo I, Nishina T, Furuhata T, et al. Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer. Ann Oncol. 2010;21:766–71.CrossRef Koizumi W, Boku N, Yamaguchi K, Miyata Y, Sawaki A, Kato T, Toh Y, Hyodo I, Nishina T, Furuhata T, et al. Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer. Ann Oncol. 2010;21:766–71.CrossRef
21.
go back to reference Harada K, Kawaguchi S, Supriatno, Onoue T, Yoshida H, Sato M. Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells. Oral Oncol. 2004;40:713–9.CrossRef Harada K, Kawaguchi S, Supriatno, Onoue T, Yoshida H, Sato M. Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells. Oral Oncol. 2004;40:713–9.CrossRef
22.
go back to reference Song GM, Tian X, Liu XL, Chen H, Zhou JG, Bian W, Chen WQ. Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis. Oncotarget. 2017;8:37963–73.PubMedPubMedCentral Song GM, Tian X, Liu XL, Chen H, Zhou JG, Bian W, Chen WQ. Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis. Oncotarget. 2017;8:37963–73.PubMedPubMedCentral
23.
go back to reference Qiu M, Peng XC, Bi F, Wang X, Li Q, Xu F, Li ZP, Shen YL, Liu JY, Zhao YQ, et al. Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer. Med Oncol. 2015;32:191.CrossRef Qiu M, Peng XC, Bi F, Wang X, Li Q, Xu F, Li ZP, Shen YL, Liu JY, Zhao YQ, et al. Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer. Med Oncol. 2015;32:191.CrossRef
Metadata
Title
Metastasis of lower gingival squamous cell carcinoma to buccinator lymph node: case report and review of the literature
Authors
Kaho Takada
Takeshi Kuroshima
Hiroaki Shimamoto
Toshimitsu Ohsako
Kou Kayamori
Tohru Ikeda
Hiroyuki Harada
Publication date
01-12-2019
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2019
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-019-1559-y

Other articles of this Issue 1/2019

World Journal of Surgical Oncology 1/2019 Go to the issue